
iiCON: Infection Innovation Consortium
@iiconnw
Saving lives by enabling pioneering infection R&D. We support industry/academic co-innovation to accelerate new treatments & preventions for infectious diseases
ID: 1144254254623928321
http://www.infectioninnovation.com 27-06-2019 14:40:48
743 Tweet
875 Followers
1,1K Following




Venue: Spaces at The Spine Event sponsors and partner: Appleyard Lees | iiCON: Infection Innovation Consortium | LSTM | ReNewVax



CCI Photonics secures £450k+ to revolutionise diagnostics. Its AI-driven InfectiScan detects bacterial infections in 15 minutes, tackling antibiotic resistance. Backed by NPIF II, iiCON, and Lyva Labs. #AI #Healthcare #Innovation Lancaster University LYVA Labs iiCON: Infection Innovation Consortium British Business Bank


iiCON: Infection Innovation Consortium has provided INFEX Therapeutics with the crucial resources needed to accelerate its R&D programmes, and progress toward life-saving therapies. Case study: lnkd.in/e3TDkmep


🎉 Celebrating Women & Girls in Science Day🔬 We recently welcomed students from Cronton College who participated in the #SwabandSend project helping in the search for the next antibiotic and the fight against #AMR. 💊 #IDWGS2025 #InternationalDayOfWomenAndGirlsInScience




Up next is the #Bionow #Partnership & #Collaboration Award sponsored by Mills & Reeve. The winner of this award is iiCON: Infection Innovation Consortium with their Infection #Innovation Consortium. Big congratulations! #BionowAwards #CelebratingSuccess






Registration now open! BactiVac Network 6th Annual Network Meeting, Edgbaston Park Hotel Hotel, Birmingham, UK. Register before 22 June 2025 to benefit from the early bird discounted rate: bit.ly/ANM6 #BactiVacEvents Wellcome Medical Research Council College of Medicine and Health (UoB)


New AI-powered, robotic labs that will accelerate development of new treatments for deadly diseases will be built at LSTM and supported by iiCON: Infection Innovation Consortium after £10m Liverpool City Region Innovation Zone funding was agreed. infectioninnovation.com/10m-funding-fo…

We’re proud partners in this year’s The Business of Science Conference in Liverpool on 15 May, which explores the future of #science & #innovation, showcasing expert voices from science & industry mixed with networking to build community & collaborations. More info: businessofscience.co.uk #BoSC25


🌍 #WorldImmunizationWeek, we're excited to share the Phase II trial of PnuBioVax - supported by @iiCONnews - is set to begin in Malawi. A major step for #VaccineEquity, driven by the MLW Research team’s expertise. ▶️tinyurl.com/44kndj8h #GlobalHealth #ClinicalResearch
